Track the 지에프씨생명과학 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 지에프씨생명과학 has recorded 47 public disclosures. Market capitalisation: €28.6bn. The latest transaction was filed on 11 August 2026 (Purchase). Among the most active insiders: 강희철. All data is accessible without an account.
36
Insider Decl.
n/a
Thresholds
€2m
22 ops.
Buy Volume
n/a
4 ops.
Sell Volume
3Σ signal
Buys €2mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,085 of 28,684 companies
35.8
score / 100
Value
27
Quality
45
FCF yld-21%
Earn yld1.9%
EV/EBITDA17.7x
ROE4.1%
Gross mgn48%
Net mgn3.1%
Debt/EBITDA3.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.